Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02753075Completed
Randomised, double-blind trial in dentin hypersensitivity (DH) (3 arms), sponsored by GSK. Primary endpoint: Change From Baseline in Schiff Sensitivity Score at 8 weeks. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02753075.